Hepatic Disorders PDF
Document Details
Uploaded by QualifiedMint
Lincoln Memorial University
Tags
Summary
This document provides information about hepatic disorders, covering anatomy and physiology, metabolic functions of the liver, assessment, and liver function tests. It also includes cirrhosis risk factors and two major complications. The document is likely study material for an undergraduate-level course.
Full Transcript
**Chapter 43: Hepatic Disorders\ **Anatomy and physiology, pg. 3673 (will not be tested on this) - Liver is located in the right upper abdomen (RUQ) w/ 4 lobes. Blood circulation:Portal vein and hepatic artery; Hepatic vein. Hepatic duct **Metabolic functions/functions of the liver, pg....
**Chapter 43: Hepatic Disorders\ **Anatomy and physiology, pg. 3673 (will not be tested on this) - Liver is located in the right upper abdomen (RUQ) w/ 4 lobes. Blood circulation:Portal vein and hepatic artery; Hepatic vein. Hepatic duct **Metabolic functions/functions of the liver, pg. 3676** - **The liver plays a major role in the metabolism of glucose and the regulation of blood glucose concentration.** - Glucose metabolism: Glycogen and glycogenolysis (breakdown of glucose) - Ammonia conversion: liver converts the metabolically generated ammonia into urea and kidneys excretes it in the urine - **As the level increases, it can cause neuro problems & lead to coma** - Protein metabolism: albumin, clotting factors - People w/ liver issues will often times have bleeding issues - Fat metabolism: liver is active in fat metabolism; fatty acids can be broken down for the production of energy and ketone bodies - **Vitamin and iron storage: large amounts of A,B,D**, several B-complex vitamins; iron and copper are also stored in the liver - Bile formation: enterohepatic circulation - Bilirubin excretion: breakdown of RBC - If pt has lots of bilirubin, they'll present w/ jaundice \[skin, eyes, urine may be yellow/dark brown\] - Drug metabolism: Bioavailability and first-pass effect (PO Meds only) - **Bioavailability** is the fraction of the given medication that actually reaches the systemic circulation - The liver metabolizes many medications (barbs, opioids, sedatives, anesthetics, and amphetamines) **Assessment, pg. 3680** - Health Hx: Exposure to hepatotoxic substances or infectious agents, lifestyle behaviors - Occupation, exposures, sexual practices, alcohol use, medications (tylenol, ketoconazole, and valproic acid), hx of ETOH and IV drug use - Questions to ask: how much ETOH do they drink? Have you ever injected IV drugs/what drugs do you use? Are you promiscuous? - **Cirrhosis risk factors**: Men: ETOH intake of 60-80 g/day Women: ETOH intake of 40-60 g/day **Liver function tests: Table 43-1, pg. 3689** - **Ammonia** - **KNOW If high levels, give lactulose \[helps excrete excess ammonia\]** - Normal: 15-45 mcg/dL - **Need sitter if LOC is altered** - Direct/total bilirubin: Measures the ability of the liver to conjugate and excrete bilirubin - Total serum protein, Serum albumin; LDH - PT/INR increased in liver disease \[this means the blood is thin\] - PTT and INR may be prolonged in liver disease (book) - AST/ALT 2:1 ratio in damage - **AST**: 8--48 units per liter (U/L). AST signifies death of tissue - **ALT**: 7--55 U/L. ALT is released when there is liver damage - Elevation usually indicates liver disease - GGT, GGTP: Values are elevated in ETOH abuse and markers for biliary cholestasis - Cholesterol: Elevated in biliary obstruction - Liver biopsy (through needle aspiration), US, CT, MRI **Physical Assessment, pg. 3683** - Jaundice, malaise & weakness, pallor, muscle atrophy, petechiae, ecchymotic areas, palmar edema, slurred speech, neuro changes (assess their recall, memory, and abstract thinking ability), pruritus, abdominal pain and enlarged liver, N/V, ascites \[weigh them daily\], SOB \[need to sit up\], edema, spider angioma, asterixis (involuntary hand flapping) **Manifestations of hepatic dysfunction, pg. 3691:** **Jaundice \[don't have to differentiate b/t 3\]** - Clinically evident: bilirubin \> 2.5 mg/dL - Increased destruction of RBCs - Hemolytic - Increased destruction of RBCs (low H/H from this) - Bilirubin predominantly unconjugated - Typically symptom free unless prolonged - Hepatocellular - Damaged liver cells, bilirubin not cleared from blood - Various causes: anorexia, infections, chronic pancreatitis, medications - Obstructive - Extrahepatic (occlusion of bile duct from gallstones, tumors) or intrahepatic (thick bile from TCAs, Seizure meds, estrogens, abx) - Bile cant flow into the intestines, gets reabsorbed by liver into blood - Deep orange, foamy urine and clay colored stools - Hereditary hyperbilirubinemia - Gilbert Syndrome: familial disorder characterized by an increased level of conjugated bilirubin that causes jaundice - Dubin Johnson syndrome (will NOT be asked about this): chronic idiopathic jaundice **Portal HTN** - **The increased pressure throughout the portal venous system that results from obstruction of blood flow into and through the damaged liver** - Two major complications: Ascites and varices **Ascites, pg. 3694** - **KNOW S/S: Increased abdominal girth, rapid wt gain, SOB, distended neck veins, and fluid & electrolyte imbalances,** umbilical hernia - The failure of the liver to metabolize aldosterone increases Na and water retention by the kidney - Figure 43-5 (**do not need to memorize** this cycle, but NOTHING stops this cycle except a liver transplant) - **Medical Management** - Nutritional: negative Na balance to reduce fluid retention. low-Na (2-g Na diet) - Avoid: table salt, salty foods, salted butter, margarin and all canned/frozen food - **Pharmacologic: diuretics (spironolactone is the first line therapy).** May also use oral furosemide - Bed rest, paracentesis, Transjugular Intrahepatic Portosystemic Shunt (TIPS) \[DON'T MEMORIZE\] - **Surgical management**: Paracentesis - Pt should be sitting in upright position (high fowlers) - **KNOW Post-op procedures for paracentesis** - **KNOW If patient had a large volume paracentesis, they may need to receive albumin which reduces risk of circulatory and renal dysfunction; want to prevent fluid shift** - **Monitor vital signs during and pre/post procedure bc** large fluid shift can cause patient to go into shock - **Nursing management**: assess, educate, document I&O, abdominal girth, daily weight, monitor resp status, **labs** (**serum ammonia, AST/ALT, bilirubin, H/H**, creatinine and electrolyte levels to assess electrolyte balance) - **Chart 43-3 home care checklist**: - **Stop all alcohol intake \[including some meds\]** - Weigh daily, Refer them to AA - Need to identify s/s of early complications: hepatic encephalopathy - state time & date of follow-up, identify support system, educate on meds, diet needs to be low sodium & moderate protein, keep all medical appointments **Esophageal Varices, pg. 3702** - Enlarged veins in lower esophagus \[sometimes higher or in stomach\] d/t blood flow blocked in liver - S/sx: hematemesis, melena, general deterioration in mental or physical status, often has hx of ETOH abuse - shock s/s: cool clammy skin, hypotension, tachycardia - Endoscopy used to identify the bleeding site - Portal hypertension measurements, Lab tests (serum bilirubin, alkaline phosphatase, serum proteins) - Medical Management - IV volume expanders/blood transfusions. Nonsurgical management is preferred - **Meds** - **KNOW Octreotide (Sandostatin): vasoactive drug that's effective in decreasing bleeding from esophageal varices, and lacks the vasoconstrictive effects of vasopressin.** - **KNOW Considered the preferred treatment regimen for immediate control of variceal bleed** - **Nursing management: monitor for mild hypoglycemia and abdominal cramping** - Preventative meds: beta-blockers: propranolol or nadolol may also use nitrates - Balloon tamponade, Endoscopic Sclerotherapy, Endoscopic Variceal Ligation/Banding, TIPS - Surgical Management - Surgical Bypass procedures: Splenorenal and mesocaval shunts - Devascularization and Transection - Nursing Management for Esophageal Varices - Monitor VS Q4H, Monitor gastrointestinal secretions and output, Assess for GI bleeding - Don\'t let them do anything that causes friction in esophagus - Coughing, sucking on straw, smoking, alcohol, probably NPO (anything to disturb mucosa) - Assess nutritional and neurological status; Mouth Care, Alcohol withdrawals, Administer blood and vit K **Hepatic Encephalopathy & Coma, pg. 3718 PRIORITY PATIENT** - **Ammonia builds up as a result from profound liver failure/damage** - Ammonia enters brains & excites astrocyte cells which stimulate GABA. GABA causes **depression of CNS producing sleep** & behavioral patterns associated w/ hepatic encephalopathy \[book\] - Other reasons ammonia buildup: GI bleeding \[bleeding esophageal varices, chronic GI bleeding\], high protein diet, bacterial infection, or uremia, ingestion of ammonium salts, - **S/sx: Altered mental status, motor disturbances, mood swings,** asterixis, constructional apraxia, fector hepaticus (chronic bad breath due to liver failure) - **Early signs**: mental change and motor changes. Pt appears confused & unkempt & has alterations in mood & sleep patterns \[book\] - Assessment/Diagnostic - **Labs: draw serum ammonia for hepatic encephalopathy** - Psychometric tests - EEG: shows general slowing with amplitude of brain waves (need to monitor for seizures) - Medical Management - **Meds**: - **Lactulose (traps ammonia in the stool; given to reduce serum ammonia levels)** - Should have @ least 2-3 stools/day - The pt receiving lactulose is monitored closely for the development of watery diarrhea stools b/c it could indicate a medication overdose (book) - Antibiotics (prevents infection) - Avoid sedatives, tranquilizers, analgesics bc liver metabolizes these & if not metabolized, this will cause further sedation - Flumazenil (Romazicon) may be useful to wake them up - Rifaximin: antibiotic that lowers levels of ammonia - IV glucose to minimize protein breakdown, vitamins \[C, A, K, thiamine\], electrolytes - May need NG tube for med admin - Daily I&O and weight, VS Q4H - **KNOW Diet: Keep daily protein intake b/t 1.2 - 1.5 g/kg body weight per day (adequate protein)** - **Avoid protein restriction if possible (book)** - **Provide small, frequent meals and 3 small snacks per day in addition\ to a late-night snack before bed (book)** - Nursing Management - Prevent bleeding and infection - **Monitor respiratory status: Deep breathe and cough & position changes** - Monitor for complications - Constipation can precipitate encephalopathy. Monitor for neuro changes - Education - Diet: do not restrict protein in hepatic encephalopathy, low sodium (\